LEADER 01257nam--2200373---450- 001 990002267150203316 005 20091126173743.0 035 $a000226715 035 $aUSA01000226715 035 $a(ALEPH)000226715USA01 035 $a000226715 100 $a20041214d1985----km-y0itay0103----ba 101 $aita 102 $aIT 105 $a||||||||001yy 200 1 $a<> nuovi profili dell'espropriazione per pubblica utilità$ei soggetti della potestà ablativa l'indennizzo$fLucio Marotta 210 $aPadova$cCEDAM$d1985 215 $aXV, 219$d24 cm 225 2 $aUrbanistica, opere pubbliche, espropriazioni$v6 410 0$12001$aUrbanistica, opere pubbliche, espropriazioni$v6 454 1$12001 461 1$1001-------$12001 606 0 $aEspropriazioni per causa di pubblica utilità 676 $a342 700 1$aMAROTTA,$bLucio$032551 801 0$aIT$bsalbc$gISBD 912 $a990002267150203316 951 $aXXIV.3. Coll. 1/ 5 (Coll. HHE 6)$b17559 E.C.$cXXIV.3. Coll. 1/ 5 (Coll. HHE)$d00247749 959 $aBK 969 $aGIU 979 $aSIAV7$b10$c20041214$lUSA01$h1109 979 $aRSIAV3$b90$c20091126$lUSA01$h1737 996 $aNuovi profili dell'espropriazione per pubblica utilità$9270245 997 $aUNISA LEADER 05718nam 2200529 450 001 9910483139103321 005 20220921164949.0 010 $a981-16-0939-X 035 $a(CKB)4100000011867223 035 $a(MiAaPQ)EBC6533385 035 $a(Au-PeEL)EBL6533385 035 $a(OCoLC)1244805490 035 $a(PPN)255296061 035 $a(EXLCZ)994100000011867223 100 $a20211022d2021 uy 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFocused ultrasound surgery in gynecology $eintroduction and application /$fFelix Wong, Lian Zhang, Zhibiao Wang 210 1$aSingapore :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (114 pages) $cillustrations 311 $a981-16-0938-1 320 $aIncludes bibliographical references. 327 $aIntro -- Foreword -- Preface -- Declaration of Interest -- Contents -- About the Authors -- Abbreviations -- 1: An Introduction -- 1.1 The HAIFU Knife® -- 1.2 The "HAIFU Knife®" -- 1.2.1 Other Focused Ultrasound Equipment Systems in the Market -- 1.2.2 Ultrasound-Guided (USg) HIFU Systems -- 1.3 MRgHIFU Systems -- 1.4 Focused Ultrasound Hyperthermia Therapy and High Intensity Focused Ultrasound Ablation -- 1.5 Conclusion -- References -- 2: Sedation and Analgesia for HIFU Ablation -- 2.1 The Choice of Drugs for Sedation and Analgesia -- 2.2 First-Line Drugs -- 2.3 Second-Line Drugs -- 2.4 Other Auxiliary Drugs Should Be Available -- 2.4.1 Sedation and Analgesia Protocol for HIFU Ablation -- 2.5 Midazolam and Fentanyl Sedation Protocol -- 2.6 Other Sedation and Analgesic Regimes: Dexmedetomidine and Remifentanil Sedation Protocol -- 2.7 Monitoring During HIFU Surgery Under Sedation -- 2.8 Treatment of Complications -- 2.8.1 Respiratory Depression -- 2.8.2 Muscle Stiffness -- 2.9 Factors Affecting the Effects of Sedation and Analgesia -- References -- 3: Ultrasound and MRI Imaging of Uterine Fibroids and Adenomyosis -- 3.1 Imaging for Uterine Fibroids -- 3.1.1 Ultrasound Imaging -- 3.2 Locations of Fibroids -- 3.2.1 MRI Imaging -- 3.3 Uterine Adenomyosis -- 3.4 Transvaginal Ultrasound Appearances of Adenomyosis -- 3.5 MRI Appearances of Adenomyosis -- 3.6 Leiomyosarcoma and Endometrial Stromal Sarcoma-MRI Features -- References -- 4: Uterine Fibroids and HIFU Ablation -- 4.1 Symptoms of Uterine Fibroids -- 4.2 Indications for Treatment -- 4.3 Investigative Methods -- 4.4 Treatments -- 4.5 HIFU Treatment -- 4.6 The USgHIFU Ablation Procedure -- 4.7 The Indications for HIFU Treatment -- 4.8 The Contraindications for HIFU Ablation -- 4.9 Preparation Before HIFU Ablation -- 4.9.1 Simulation Test. 327 $a4.10 Other Preparations -- 4.11 HIFU Ablation -- 4.12 Factors Influencing HIFU Effectiveness -- 4.13 The Types and Locations of Fibroids that Affect HIFU Ablation -- 4.14 Assessment of the Effectiveness of the Ablation at the End of HIFU Ablation Procedure -- 4.15 Post-HIFU Ablation Care -- 4.16 Postoperative Follow-up -- 4.17 Results of HIFU Ablation on Follow-up -- 4.17.1 The Non-perfused Volume Ratio -- 4.17.2 The Volume Reduction After HIFU Ablation -- 4.18 Other Issues of Fibroid Ablation -- 4.19 Recurrence of Fibroids -- 4.20 Pregnancy After HIFU Ablation -- References -- 5: Adenomyosis and HIFU Ablation -- 5.1 The Symptoms of Adenomyosis -- 5.2 Treatment of Adenomyosis -- 5.2.1 Drug Treatment -- 5.2.1.1 Mirena (LNG-IUS) -- 5.2.1.2 Gonadotropin-Releasing Hormone Agonist (GnRH-a) -- 5.2.1.3 Oral Contraceptives -- 5.2.2 Surgical Treatment -- 5.2.3 Bilateral Uterine Artery Embolization (UAE) -- 5.2.4 High Intensity Focused Ultrasound (HIFU) Therapy -- 5.3 Factors Influencing HIFU Effectiveness for Adenomyosis Treatment are Listed as Follow -- 5.4 Advantages of HIFU Treatment for Adenomyosis -- 5.5 Pregnancy -- References -- 6: Complications of HIFU Ablation -- 6.1 Fever -- 6.2 Pain -- 6.3 Skin Burn Injury -- 6.4 Urinary Tract Injury -- 6.5 Bowel Injury -- 6.6 Vaginal Bleeding or Discharge -- 6.7 Other Rare Complications or Those Not Reported -- References -- 7: Fertility and Pregnancy After HIFU Ablation -- 7.1 The Reproductive Impact After HIFU Ablation for Uterine Fibroids -- 7.1.1 HIFU Impact on Ovarian Functions -- 7.1.2 HIFU Impact on Uterine Function -- 7.1.3 Risks of Miscarriage After HIFU Ablation -- 7.1.4 The Cesarean Section Rate After HIFU Ablation -- 7.2 The Reproductive Impact After HIFU Ablation for Adenomyosis -- 7.3 Conclusion -- References -- 8: Other Issues of HIFU Treatment. 327 $a8.1 MRI-Guided and Ultrasound-Guided HIFU Ablation -- 8.2 HIFU Ablation and HIFU Hyperthermia -- 8.3 Malignant Fibroids -- 8.4 Multiple Fibroids -- 8.5 The Cost of HIFU Treatment -- References -- 9: Other HIFU Ablation Applications in Gynecology and Related to Obstetrics -- 9.1 Abnormal Placenta Attachment-Placenta Accreta -- 9.2 Cesarean Scar Pregnancy (CSP) -- 9.3 Abdominal Wall Endometriosis -- References. 606 $aGynecology 606 $aCirurgia obstètrica$2thub 606 $aUltrasons en medicina$2thub 608 $aLlibres electrònics$2thub 615 0$aGynecology. 615 7$aCirurgia obstètrica 615 7$aUltrasons en medicina 676 $a300 700 $aWong$b Felix$01226752 702 $aZhang$b Lian 702 $aWang$b Zhibiao 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910483139103321 996 $aFocused ultrasound surgery in gynecology$92848467 997 $aUNINA